Amdocs Net Worth

Amdocs Net Worth Breakdown

  DOX
The net worth of Amdocs is the difference between its total assets and liabilities. Amdocs' net worth represents the value of the company's equity or ownership interest. In other words, it is the amount of money that would be left over if all of Amdocs' assets were sold and all of its debts were paid off. Net worth is sometimes referred to as shareholder's equity or book value. Amdocs' net worth can be used as a measure of its financial health and stability which can help investors to decide if Amdocs is a good investment. It is also essential in determining the company's creditworthiness and ability to secure financing before investing in Amdocs stock.

Amdocs Net Worth Analysis

Amdocs' net worth analysis, or its valuation, is the process of determining the total value of the company. This involves assessing a range of factors, including Amdocs' financial performance, assets, liabilities, and potential for growth. The ultimate goal is to provide a clear understanding of Amdocs' overall worth, which can help investors make informed investment decisions. There are several methods that can be used to perform Amdocs' net worth analysis. One common approach is to calculate Amdocs' market capitalization.Another approach is to use the price-to-earnings ratio (P/E ratio), which compares Amdocs' stock price to its earnings per share (EPS). Discounted cash flow (DCF) analysis is another popular method for assessing Amdocs' net worth. This approach calculates the present value of Amdocs' future cash flows, taking into account factors such as growth rate, profitability, and risk. By comparing the present value of Amdocs' cash flows to its current stock price, investors can gain a better understanding of the company's overall value. Finally, investors may use comparable company analysis to evaluate Amdocs' net worth. This involves comparing Amdocs' financial metrics to similar companies in the same industry. By identifying companies with similar financial characteristics, investors can gain insight into Amdocs' net worth relative to its peers.

Enterprise Value

6.55 Billion

To determine if Amdocs is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding Amdocs' net worth research are outlined below:
Latest headline from thelincolnianonline.com: Advisor OS LLC Raises Stock Holdings in Amdocs Limited

Amdocs Quarterly Good Will

2.88 Billion

Amdocs uses earnings reports to provide investors with an update of all three financial statements, including the income statement, the balance sheet, and the cash flow statement. Therefore, it is also crucial when considering investing in Amdocs. Every quarterly earnings report provides investors with an overview of sales, expenses, and net income for the most recent period. It also may provide a comparison to Amdocs' previous reporting period. The quarterly earnings reports are usually disseminated to the public via Form 10-Q, which is a legal document filed with the Securities and Exchange Commission every quarter.
6th of February 2024
Upcoming Quarterly Report
View
8th of May 2024
Next Financial Report
View
31st of December 2023
Next Fiscal Quarter End
View
5th of November 2024
Next Fiscal Year End
View
30th of September 2023
Last Quarter Report
View
30th of September 2023
Last Financial Announcement
View

Know Amdocs' Top Institutional Investors

Have you ever been surprised when a price of an equity instrument such as Amdocs is soaring high without any particular reason? This is usually happening because many institutional investors are aggressively trading Amdocs backward and forwards among themselves. Amdocs' institutional investor refers to the entity that pools money to purchase Amdocs' securities or originate loans. Institutional investors include commercial and private banks, credit unions, insurance companies, pension funds, hedge funds, endowments, and mutual funds. Operating companies that invest excess capital in these types of assets may also be included in the term and may influence corporate governance by exercising voting rights in their investments.
Shares
American Century Companies Inc2025-03-31
2.2 M
Dimensional Fund Advisors, Inc.2025-03-31
2.1 M
Alliancebernstein L.p.2025-03-31
1.9 M
Morgan Stanley - Brokerage Accounts2025-03-31
1.9 M
Geode Capital Management, Llc2025-03-31
1.8 M
Nordea Investment Mgmt Bank Demark A/s2025-03-31
1.6 M
State Street Corp2025-03-31
1.4 M
Bank Of America Corp2025-03-31
1.2 M
Neuberger Berman Group Llc2025-03-31
M
Fmr Inc2025-03-31
16.6 M
Hhg Plc2025-03-31
6.7 M
Note, although Amdocs' institutional investors appear to be way more sophisticated than retail investors, it remains unclear if professional active investment managers can reliably enhance risk-adjusted returns by an amount that exceeds fees and expenses.

Follow Amdocs' market capitalization trends

The company currently falls under 'Mid-Cap' category with a total capitalization of 9.83 B.

Market Cap

6.88 Billion

Project Amdocs' profitablity

Last ReportedProjected for Next Year
Return On Tangible Assets 0.13  0.10 
Return On Capital Employed 0.15  0.14 
Return On Assets 0.07  0.06 
Return On Equity 0.13  0.07 
The company has Net Profit Margin of 0.11 %, which implies that it may need a different competitive strategy as even a very small decline in it revenue may erase profits and result in a net loss. This is way below average. In the same way, it shows Net Operating Margin of 0.18 %, which entails that for every 100 dollars of revenue, it generated $0.18 of operating income.
When accessing Amdocs' net worth, it's important to look at multiple sources and consider different scenarios. For example, gross profit margin measures Amdocs' profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of Amdocs' profitability and make more informed investment decisions.
Please note, the imprecision that can be found in Amdocs' accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of Amdocs. Check Amdocs' Beneish M Score to see the likelihood of Amdocs' management manipulating its earnings.

Evaluate Amdocs' management efficiency

Amdocs has Return on Asset of 0.0783 % which means that on every $100 spent on assets, it made $0.0783 of profit. This is way below average. In the same way, it shows a return on shareholders' equity (ROE) of 0.1535 %, implying that it generated $0.1535 on every 100 dollars invested. Amdocs' management efficiency ratios could be used to measure how well Amdocs manages its routine affairs as well as how well it operates its assets and liabilities. Return On Tangible Assets is likely to drop to 0.10 in 2025. Return On Capital Employed is likely to drop to 0.14 in 2025. At this time, Amdocs' Non Currrent Assets Other are fairly stable compared to the past year. Net Tangible Assets is likely to rise to about 676.1 M in 2025, whereas Total Assets are likely to drop slightly above 4.6 B in 2025.
Last ReportedProjected for Next Year
Book Value Per Share 27.80  29.19 
Tangible Book Value Per Share 3.92  3.78 
Enterprise Value Over EBITDA 14.54  15.35 
Price Book Value Ratio 2.58  1.42 
Enterprise Value Multiple 14.54  15.35 
Price Fair Value 2.58  1.42 
Enterprise Value7.9 B6.6 B
The management team at Amdocs has a track record of steering the company towards sustained growth. Evaluating their strategies helps in understanding the stock's long-term potential.
Enterprise Value Revenue
2.1972
Revenue
4.8 B
Quarterly Revenue Growth
(0.09)
Revenue Per Share
41.909
Return On Equity
0.1535

Amdocs Corporate Filings

6K
19th of May 2025
A report filed by foreign private issuers with SEC. A foreign private issuer is a non-U.S. company with securities traded on U.S. exchanges.
ViewVerify
14th of May 2025
Other Reports
ViewVerify
17th of December 2024
Other Reports
ViewVerify
13A
14th of November 2024
An amended filing to the original Schedule 13G
ViewVerify
Amdocs time-series forecasting models is one of many Amdocs' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models ae widely used for non-stationary data. Non-stationary data are called the data whose statistical properties e.g. the mean and standard deviation are not constant over time but instead, these metrics vary over time. These non-stationary Amdocs' historical data is usually called time-series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the market movement and maximize returns from investment trading.

Amdocs Earnings per Share Projection vs Actual

Amdocs Corporate Management

Darcy AntonellisHead MediaProfile
Oren MarmurHead NetworkProfile
Gary MilesChief OfficerProfile
Matthew SmithCorporate SecretaryProfile
Mustafa OyumiHead StrategyProfile

Additional Tools for Amdocs Stock Analysis

When running Amdocs' price analysis, check to measure Amdocs' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Amdocs is operating at the current time. Most of Amdocs' value examination focuses on studying past and present price action to predict the probability of Amdocs' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Amdocs' price. Additionally, you may evaluate how the addition of Amdocs to your portfolios can decrease your overall portfolio volatility.